Clinical trial NCT01721928 - References

Acute Kidney Injury — Norwegian Intensive Care Unit Dalteparin Effect Study

Citation(s)

•   Cook D, Crowther MA, Douketis J; VTE in the ICU Workshop Participants
  Thromboprophylaxis in medical-surgical intensive care unit patients. J Crit Care. 2005 Dec;20(4):320-3. Review.
•   Cook D, Douketis J, Crowther MA, Anderson DR; VTE in the ICU Workshop Participants
  The diagnosis of deep venous thrombosis and pulmonary embolism in medical-surgical intensive care unit patients. J Crit Care. 2005 Dec;20(4):314-9. Review.
•   Cook D, Meade M, Guyatt G, Griffith L, Granton J, Geerts W, Crowther M; Canadian Critical Care Trials Group
  Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists. Crit Care. 2004 Jun;8(3):R145-52. Epub 2004 May 6.
•   Cook DJ, Crowther MA, Geerts WH
  On the need for a workshop on venous thromboembolism in critical care. J Crit Care. 2005 Dec;20(4):306-8.
•   Cook DJ, Crowther MA, Meade MO, Douketis J; VTE in the ICU Workshop Participants
  Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients. J Crit Care. 2005 Dec;20(4):309-13.
•   Cook DJ, Douketis J, Arnold D, Crowther MA
  Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Curr Opin Pulm Med. 2009 Sep;15(5):455-62. doi: 10.1097/MCP.0b013e32832ea4dd. Review.
•   Cook DJ, Rocker G, Meade M, Guyatt G, Geerts W, Anderson D, Skrobik Y, Hebert P, Albert M, Cooper J, Bates S, Caco C, Finfer S, Fowler R, Freitag A, Granton J, Jones G, Langevin S, Mehta S, Pagliarello G, Poirier G, Rabbat C, Schiff D, Griffith L, Crowther M; PROTECT Investigators; Canadian Critical Care Trials Group
  Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. J Crit Care. 2005 Dec;20(4):364-72.
•   Crowther MA, Cook DJ, Griffith LE, Devereaux PJ, Rabbat CC, Clarke FJ, Hoad N, McDonald E, Meade MO, Guyatt GH, Geerts WH, Wells PS
  Deep venous thrombosis: clinically silent in the intensive care unit. J Crit Care. 2005 Dec;20(4):334-40.
•   Crowther MA, Cook DJ, Griffith LE, Meade M, Hanna S, Rabbat C, Bates SM, Geerts W, Johnston M, Guyatt G
  Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med. 2005 Jan;31(1):48-55. Epub 2004 Dec 9.
•   Douketis JD, Rabbat C, Crowther MA; VTE in the ICU Workshop Participants
  Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency. J Crit Care. 2005 Dec;20(4):324-9. Review.
•   Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW
  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008 Jun;133(6 Suppl):381S-453S. doi: 10.1378/chest.08-0656.
•   Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB
  Prevention of venous thromboembolism. Chest. 2001 Jan;119(1 Suppl):132S-175S. Review.
•   Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG
  Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):338S-400S. Review.
•   Haas FJ, Kluft C, Biesma DH, Schutgens RE
  Patients with deep venous thrombosis and thrombophilia risk factors have a specific prolongation of the lag time in a chromogenic thrombin generation assay. Blood Coagul Fibrinolysis. 2011 Sep;22(6):506-11. doi: 10.1097/MBC.0b013e328347404d.
•   Khouli H, Shapiro J, Pham VP, Arfaei A, Esan O, Jean R, Homel P
  Efficacy of deep venous thrombosis prophylaxis in the medical intensive care unit. J Intensive Care Med. 2006 Nov-Dec;21(6):352-8.
•   Klein SM, Slaughter TF, Vail PT, Ginsberg B, El-Moalem HE, Alexander R, D'Ercole F, Greengrass RA, Perumal TT, Welsby I, Gan TJ
  Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: a comparison with anti-Xa concentrations. Anesth Analg. 2000 Nov;91(5):1091-5.
•   Leclerc JR, Gent M, Hirsh J, Geerts WH, Ginsberg JS
  The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group. Chest. 1998 Aug;114(2 Suppl Evidence):115S-118S.
•   Makris PE, Pithara E
  Clinical evaluation of new global clotting assay for monitoring of LMWH treatment: pilot study. Int Angiol. 1998 Jun;17(2):69-79.
•   Malinoski D, Ewing T, Patel MS, Jafari F, Sloane B, Nguyen B, Barrios C, Kong A, Cinat M, Dolich M, Lekawa M, Hoyt DB
  Risk factors for venous thromboembolism in critically ill trauma patients who cannot receive chemical prophylaxis. Injury. 2013 Jan;44(1):80-5. doi: 10.1016/j.injury.2011.10.006. Epub 2011 Nov 1.
•   Malinoski D, Jafari F, Ewing T, Ardary C, Conniff H, Baje M, Kong A, Lekawa ME, Dolich MO, Cinat ME, Barrios C, Hoyt DB
  Standard prophylactic enoxaparin dosing leads to inadequate anti-Xa levels and increased deep venous thrombosis rates in critically ill trauma and surgical patients. J Trauma. 2010 Apr;68(4):874-80. doi: 10.1097/TA.0b013e3181d32271.
•   Marik PE, Andrews L, Maini B
  The incidence of deep venous thrombosis in ICU patients. Chest. 1997 Mar;111(3):661-4.
•   McCunn M, Reynolds HN, Reuter J, McQuillan K, McCourt T, Stein D
  Continuous renal replacement therapy in patients following traumatic injury. Int J Artif Organs. 2006 Feb;29(2):166-86. Review.
•   Patel R, Cook DJ, Meade MO, Griffith LE, Mehta G, Rocker GM, Marshall JC, Hodder R, Martin CM, Heyland DK, Peters S, Muscedere J, Soth M, Campbell N, Guyatt GH; Burden of Illness in venous ThromboEmbolism in Critical care (BITEC) Study Investigators; Canadian Critical Care Trials Group
  Burden of illness in venous thromboembolism in critical care: a multicenter observational study. J Crit Care. 2005 Dec;20(4):341-7.
•   Rabbat CG, Cook DJ, Crowther MA, McDonald E, Clarke F, Meade MO, Lee KA, Cook RJ
  Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. J Crit Care. 2005 Dec;20(4):357-63.
•   Ribic C, Lim W, Cook D, Crowther M
  Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review. J Crit Care. 2009 Jun;24(2):197-205. doi: 10.1016/j.jcrc.2008.11.002. Epub 2009 Feb 7. Review.
•   Schleyer AM, Schreuder AB, Jarman KM, Logerfo JP, Goss JR
  Adherence to guideline-directed venous thromboembolism prophylaxis among medical and surgical inpatients at 33 academic medical centers in the United States. Am J Med Qual. 2011 May-Jun;26(3):174-80. doi: 10.1177/1062860610382289. Epub 2011 Apr 13.
•   Spyropoulos AC, Anderson FA Jr, FitzGerald G, Decousus H, Pini M, Chong BH, Zotz RB, Bergmann JF, Tapson V, Froehlich JB, Monreal M, Merli GJ, Pavanello R, Turpie AGG, Nakamura M, Piovella F, Kakkar AK, Spencer FA; IMPROVE Investigators
  Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011 Sep;140(3):706-714. doi: 10.1378/chest.10-1944. Epub 2011 Mar 24.
•   Swarczinski C, Dijkers M
  The value of serial leg measurements for monitoring deep vein thrombosis in spinal cord injury. J Neurosci Nurs. 1991 Oct;23(5):306-14.
•   Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA
  Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma. 2009 Jun;66(6):1509-15; discussion 1515-7. doi: 10.1097/TA.0b013e3181a51e33.

Norwegian Intensive Care Unit Dalteparin Effect Study

Details for clinical trial NCT01721928